Overdiagnosis in mammography screening;Overdiagnostisering ved mammografiscreening

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 17, 2004, Pages 2238-2239

  Zahl, Per Henrik ^a   Mæhlen, Jan ^b  

^a Nasjonalt Folkehelseinstitutt ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; SCREENING; SWEDEN; BREAST TUMOR; INCIDENCE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY;

AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES;

EID: 4644367091     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zahl PH, Strand BH, Mæhlen J. Breast cancer incidence in Norway and Sweden during introduction of nation-wide screening: prospective cohort study. BMJ 2004; 328: 921-4.
2. Fracheboud J, de Koning HJ, Beemsterboer PMM et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999; 81: 912-7.
3. Ertzaas AKO, Hofvind SSH, Thoresen SØ. Mammografiprogrammet i Norge. Evaluering av prøveprosjektet 1996-2000. Oslo: Kreftregisteret, 2000.
4. Ederer F, Axtell LM, Cutler S. The relative survival rate: a statistical methodology. National Cancer Institute Monograph 1961; 6: 101-21.
5. Woodman CBJ, Threlfall AG, Boggis CRM et al. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 1995; 310: 224-6.
6. Wang H, Bjurstam N, Bjørndal H et al. Interval cancers in the Norwegian breast cancer screening program. Int J Cancer 2001; 94: 594-8.
7. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-2.
8. Wang H, Hofvind S, Tretli S et al. Reduserer organisert mammografiscreening dødelighet av brystkreft? Tidsskr Nor Lægeforen 2002; 122: 551.
9. Boer R, Mamerdam P, de Koning H et al. Extra incidence caused by mammographic screening. Lancet 1994; 343: 979.
10. Horton R. Screening mammography-an overview revisited. Lancet 2001; 358: 1284-5.
11. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003; 348: 1672-80.
12. Etzioni R, Penson DF, Legier JM et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981-90.
13. van Oortmarssen GJ, Habbema JDF, van der Maas PJ et al. A model for breast cancer screening. Cancer 1990; 66: 1601-12.
14. Tabár L, Fagerberg CJG, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1: 829-32.